title: Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection.
abstract: We have constructed a chimeric protein composed of the receptor binding and membrane translocation domains of Pseudomonas exotoxin A (PE) with the outer membrane proteins I and F, together designated as PEIF. The potential of PEIF as a vaccine against Pseudomonas infection was evaluated in BALB/c mice and New Zealand white rabbits. We examined titers of anti-PE and anti-OprF antibodies, and the ability both to neutralize PE cytotoxicity and to increase opsonophagocytic uptake of Pseudomonas aeruginosa strain PAO1, serogroups 2 and 6. The results showed that PEIF can induce antibodies not only to neutralize the PE cytotoxicity but also to promote the uptake of various strains of P. aeruginosa by murine peritoneal macrophages. In a burned mouse model, PEIF afforded significant protection against infection by the homologous P. aeruginosa strain PAO1, heterologous serogroup 2, and the PE hyperproducing strain PA103. These observations thus indicate that PEIF may be used as a novel vaccine against P. aeruginosa infection.
authors.affiliation: Institute of Genetics, School of Life Sciences, National Yang-Ming University, Taipei, Taiwan, ROC.
authors.forename: T Y
authors.initials: TY
authors.lastname: Chen
authors.forename: H F
authors.initials: HF
authors.lastname: Shang
authors.forename: T L
authors.initials: TL
authors.lastname: Chen
authors.forename: C P
authors.initials: CP
authors.lastname: Lin
authors.forename: C F
authors.initials: CF
authors.lastname: Hui
authors.forename: J
authors.initials: J
authors.lastname: Hwang
mesh_terms: D036002:ADP Ribose Transferases; D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood / Q000494:pharmacology; D000918:Antibody Specificity; D001426:Bacterial Proteins / Q000276:immunology*; D001427:Bacterial Toxins; D001428:Bacterial Vaccines / Q000276:immunology*; D005098:Exotoxins / Q000276:immunology*; D008074:Lipoproteins / Q000276:immunology*; D017737:Macrophages, Peritoneal / Q000276:immunology; D051379:Mice; D008807:Mice, Inbred BALB C; D018272:Porins / Q000276:immunology*; D011552:Pseudomonas Infections / Q000517:prevention & control; D011550:Pseudomonas aeruginosa / Q000276:immunology*; D011817:Rabbits; D011994:Recombinant Proteins / Q000276:immunology; D014614:Vaccines, Synthetic / Q000276:immunology*; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A
chemical_list: D036002:ADP Ribose Transferases; D000907:Antibodies, Bacterial; D001426:Bacterial Proteins; D001427:Bacterial Toxins; D001428:Bacterial Vaccines; D005098:Exotoxins; D008074:Lipoproteins; D018272:Porins; D011994:Recombinant Proteins; D014614:Vaccines, Synthetic; D037521:Virulence Factors; D000097668:Pseudomonas aeruginosa Exotoxin A; C060507:outer membrane lipoprotein I, Bacteria